Flow cytometry results showed that the combination of anti-PD-L1 with ArgNP promoted infiltration of CD8+ Teff cells and elevated the ratio of CD8+/CD4+ T cells in tumor tissues (Figure 8B). Here, CD4 is linked to neoplasm.